key: cord-0891318-si5w40s4
authors: Lang, Angela L.; Shaw, Kendrick M.; Lozano, Rodrigo; Wang, Jingping
title: Effectiveness of a negative-pressure patient isolation hood shown using particle count
date: 2020-05-15
journal: Br J Anaesth
DOI: 10.1016/j.bja.2020.05.002
sha: a6ab8b27158a48683b4fa6d081614cde9087cc5e
doc_id: 891318
cord_uid: si5w40s4

nan

Editor -The critical shortage of medical supplies, including personal protective equipment, during the COVID-19 pandemic has compelled clinicians to look for additional ways to protect themselves from aerosolized particles during airway management. Although a few devices with a similar goal have been described 1,2 , limitations remain, including lack of containment and effective removal of aerosols and the need for sterilization. We developed a negative pressure patient isolation hood that is disposable to reduce sterilization risks, and is coupled to negative pressure generated by smoke evacuators to achieve coronavirus source control during aerosolgenerating procedures (Video 1).

A humidifier generating supraphysiologic amounts of aerosolized particles was used for testing to ensure efficacy even at extreme conditions (eFigure 1). Most particles generated from human respiratory sources during coughing, sneezing, and talking are droplet nuclei 0.5-5.0 μm in diameter 3 . A particle counter with a size detection range of 0.3 -10 µm was placed inside the hood, and a second counter was placed outside of the hood at approximately the height of the clinician's head. With continuous aerosolization, particle counts inside the hood were more than 100-fold greater than that generated by a cough 4 . With the humidifier running continuously, the particle counter at the height of the clinician's head detected 700 [interquartile range 570-800] L -1 aerosolized particles without the protection of a negative-pressure patient isolation hood. In contrast, the particle count was 18 [0-30] L -1 with the hood (Figure 1 ). Particle count from inside the hood decreased by 63% when the smoke evacuator was generating 230 L min -1 of air flow, showing effective aerosol removal.

To compare aerosol clearance with and without negative pressure, the humidifier was turned off to simulate the end of an aerosol-generating procedure. Without negative pressure, 183 min was required for the particle count to decrease by 98%, compared to 5 min when negative pressure was applied (eFigure 2). While visual inspection corelated with the removal of large aerosolized particles (greater than 10 µm), it was highly unreliable at determining degree of removal of small aerosolized particles, as the hood appeared clear when particle count of particles greater than 0.5 µm was well above 200,000 L -1 .

Limitations of the negative-pressure patient isolation hood device include: 1) the time required for setup, albeit a few minutes, might preclude its use in emergency situations; 2) while aerosolized particles are efficiently removed by negative pressure, particles that adhere to the inner surface of the hood remain a source for contamination, so training is required to disassemble and discard the plastic drape; 3) particles < 0.3 µm in size were not measured, although smaller particles may be more susceptible to removal by negative pressure 5 ; 4) the air in the hood reaches the smoke evacuator and passes through an ultra-low particulate air (ULPA)grade filter that is rated to remove 99.999% of particles > 100 µm in size. Filtered air is then recirculated back to the operating room. The filter has a limited plume evacuation time, thus the need for replacement adds to the cost of using the device.

Despite these limitations, the negative-pressure patient isolation hood is expected to reduce the exposure of healthcare workers to aerosols during aerosol-generating procedures such as tracheal intubation, extubation, and bronchoscopy, and thus may decrease the risk of viral transmission. It may also reduce the risk of cross contamination between patients in operating rooms. The utility of the hood can be broadened to most situations in which direct patient contact is required, such as transportation, other bedside aerosolgenerating procedures (e.g. tracheostomy, tracheal tube suctioning, open circuit) and during phlebotomy. The negative-pressure patient isolation hood might also enable liberalized use of noninvasive ventilation strategies during the present pandemic in the setting of ventilator shortages. We recommend use of particle counters to study the effectiveness of similar protective devices as most devices have not been properly tested and may therefore provide a false sense of security and put their users at increased risk of exposure to droplets and aerosols. 

Barrier Enclosure during Endotracheal Intubation

Clear plastic drapes may be effective at limiting aerosolization and droplet spray during extubation: implications for COVID-19

Airborne particle sizes and sources found in indoor air

Quantity and size distribution of cough-generated aerosol particles produced by influenza patients during and after illness

Effects of air exchange rate, particle size and injection place on particle concentrations within a reduced-scale room

The authors have no conflicts of interest ot declare.This video illustrates the material, installation and use of the negative pressure patient isolation hood. We could not directly upload the video due to the submission size limit of 60MB. The video was uploaded to Dropbox Business at Partners HealthCare, a platform that is compliant with our institution's policies and procedures. The video is not open to public, and can only be viewed or downloaded using this link:https://www.dropbox.com/s/tmy6de9sv41yfrc/negative_pressure_hood.mp4?dl=0